PRE Stock Overview
A genomics-driven health sciences company, engages in revolutionizing prevention, early detection, and treatment in Taiwan, Hong Kong, the United Kingdom, and internationally.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 2/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Prenetics Global Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$5.99 |
52 Week High | US$15.00 |
52 Week Low | US$2.85 |
Beta | -0.28 |
1 Month Change | 14.53% |
3 Month Change | 20.28% |
1 Year Change | -57.97% |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -94.86% |
Recent News & Updates
Prenetics Global Limited (NASDAQ:PRE) Looks Just Right With A 29% Price Jump
May 29Prenetics Global Limited's (NASDAQ:PRE) 36% Cheaper Price Remains In Tune With Revenues
Apr 08Recent updates
Prenetics Global Limited (NASDAQ:PRE) Looks Just Right With A 29% Price Jump
May 29Prenetics Global Limited's (NASDAQ:PRE) 36% Cheaper Price Remains In Tune With Revenues
Apr 08Prenetics Global Limited (NASDAQ:PRE) Held Back By Insufficient Growth Even After Shares Climb 30%
Jan 07Prenetics Global GAAP EPS of -$2.91, revenue of $51.72M
Sep 09Shareholder Returns
PRE | US Healthcare | US Market | |
---|---|---|---|
7D | 4.0% | 0.3% | -0.6% |
1Y | -58.0% | 1.3% | 22.5% |
Return vs Industry: PRE underperformed the US Healthcare industry which returned 1.7% over the past year.
Return vs Market: PRE underperformed the US Market which returned 22.2% over the past year.
Price Volatility
PRE volatility | |
---|---|
PRE Average Weekly Movement | 16.7% |
Healthcare Industry Average Movement | 6.5% |
Market Average Movement | 5.8% |
10% most volatile stocks in US Market | 15.7% |
10% least volatile stocks in US Market | 2.9% |
Stable Share Price: PRE's share price has been volatile over the past 3 months.
Volatility Over Time: PRE's weekly volatility has increased from 12% to 17% over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | 322 | Danny Yeung | www.prenetics.com |
Prenetics Global Limited, a genomics-driven health sciences company, engages in revolutionizing prevention, early detection, and treatment in Taiwan, Hong Kong, the United Kingdom, and internationally. It operates through two segments: Prevention and Diagnostics. The company offers CircleDNA, a consumer genetic testing product to offer comprehensive DNA test.
Prenetics Global Limited Fundamentals Summary
PRE fundamental statistics | |
---|---|
Market cap | US$73.18m |
Earnings (TTM) | -US$54.35m |
Revenue (TTM) | US$21.74m |
3.4x
P/S Ratio-1.3x
P/E RatioIs PRE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
PRE income statement (TTM) | |
---|---|
Revenue | US$21.74m |
Cost of Revenue | US$12.91m |
Gross Profit | US$8.83m |
Other Expenses | US$63.18m |
Earnings | -US$54.35m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -4.45 |
Gross Margin | 40.61% |
Net Profit Margin | -249.95% |
Debt/Equity Ratio | 0% |
How did PRE perform over the long term?
See historical performance and comparison